1,5-anhydro-D-fructose (AF) in organisms was first reported in fungi. Later, Yu et al. purified and characterized the enzyme which catalyzes the degradation of -1,4-glucan (such as glycogen and starch) into AF from red algae 1) and they termed this the AF pathway. After that, AF pathway was reported in wide variety of organisms such as bacteria, 2) fungi, higher plants and mammals. 3) In some organisms, AF is catabolized to antimicrobials, an antioxidant, an anti-freezing agent, or 1,5-anhydro-D-mannitol. But in most organisms, it is reduced to 1,5-anhydro-D-glucitol (AG). 2, 3) AG is the 1-deoxy form of glucopyranose. In human body fluid, AG concentration is about 1/40 of glucose level, and is the second most abundant polyol. In the mammalian body, it is chemically highly stable; the only known metabolic reaction is reversible phosphorylation of the C 6 hydroxyl group. Despite its metabolic inertness, the AG level in body fluid is definitely controlled by certain mechanisms. It is not influenced by hormones, food intake, or starvation. But when the hyperglycemic state is continued, AG is excreted in the urine together with glucose, and the blood AG level is reduced drastically. Hence, the blood AG level is used as clinical marker of diabetes mellitus.
The mammalian cell membrane has high permeability to AG, comparable to glucose. 4) But although AG is analogous to glucose, it is suggested that it is transported not by the glucose transporter, but by an AG specific transporter.
4) The existence of an AG maintaining system implies that AG has an important physiological function.
Shiga et al. reported that Esherichia coli C600 steadily degrades about 1/1,000 portion of accumulated glycogen to AF, and that AF is reduced to AG when the glucose in the medium is exhausted.
2) They also reported that AG in the medium accelerates glycogen utilization.
2) Based on these findings, they suggested that the glycogen metabolism controls the AF pathway, and that AG is an extracellular signaling molecule in bacteria.
2)
The AF concentration and the glycogen contents in various rat organs are positively correlated.
3) Human K562 erythroleukemia cells reduce AF in culture medium, 5) but the reducing activity is strongly suppressed by a physiological level of glucose. 5) Hence, a relation between glycogen metabolism and the AF pathway is probable also in mammalian cells.
Based on partial amino acid sequences obtained from pig liver AF reductase, 6) we searched for the putative mouse AF reductase gene by BLAST search (tblastn). The result showed that AKR1E1 (aldo-keto reductase family 1, member E1) had the highest homology in the database (66% of the residues were identical). Bohren et al. cloned and expressed this cDNA, and determined some properties of the recombinant protein. 7) Azuma et al. cloned and expressed human testis specific ortholog. 8) But neither group determined the physiological function of this enzyme.
As shown in Fig. 1A , mouse aldose reductase also has high homology to AKR1E1 (61% of the residues were identical). But, as shown in Fig. 1B , most of residues which constitute the substrate binding pocket 9) were y To whom correspondence should be addressed. Tel/Fax: +81-3-5454-6869; E-mail: kubota@idaten.c.u-tokyo.ac.jp Abbreviations: AF, 1,5-anhydro-D-fructose; AG, 1,5-anhydro-D-glucitol; AKR, aldo-keto reductase; AKR1E1, aldo-keto reductase family 1, member E1 identical or similar as between AKR1E1 and pig AF reductase, but about half of the pocket residues were different as between AKR1E1 and aldose reductase.
In addition, complemental parts for aldose reductase's 214th to 219th amino acid residues were deleted both in pig AF reductase and AKR1E1 (Fig. 1A) . These residues were part of the aldo-keto reductase family's common motif called the B-loop, which is thought to be related to substrate specificity. 9) From these facts, it is likely that AKR1E1 is AF reductase of the mouse.
Mouse liver total RNA (from C57BL/6J strain, 8-week-old male) was used as a starting material for cloning of the AKR1E1 gene. First strand cDNA synthesis was performed using a Superscript II reverse transcription kit (Invitrogen, Carlsbad, CA) using oligo (dT) as a primer. Subsequent PCR was carried out using ExTaq polymerase (Takara Bio, Ohsu, Japan), a forward primer (5 0 -AATCCGGATCCACCATG-GAAAACATCCC-3 0 ; the NcoI site underlined) and a reverse primer ( A, Sequences of mouse aldose reductase were obtained from the NCBI database. Alignment was performed using the program blastp. Residues of pig AF reductase and mouse aldose reductase that are identical to AKR1E1 are shaded. Framed residues are residues that form B-loop. B, Substrate binding pocket residues of mouse aldose reductase are aligned with the corresponding residues of AKR1E1 and pig AF reductase. Residues in the gray box were residues identical or similar to mouse aldose reductase. Residues in the black box were residues identical or similar only as between AKR1E1 and pig AF reductase. n.d., not determined. --, corresponding residue does not exist.
GTGGAAAGG-3
0 ; the XhoI site is underlined). Primers were designed to contain restriction sites for sitedirectied ligation to pTriEx4 multisystem expression vector (Novagen, Darmstadt, Germany). Amplified PCR products were ligated to pGEM-T (Promega, Madison, WI) TA-cloning vector, and the resulting vector was digested in two ways by NcoI-BstXI double-digestion and BstXI-XhoI double-digestion, because AKR1E1 has another NcoI site within the ORF. The resulting fragments were ligated to pTriEX4 vector using DNA ligation kit ver. 2.1 (Takara).
For bacterial protein expression, we used E. coli strain BL21 (DE3) pLysS as host cells. Plasmidharboring bacteria were grown in 50 ml of Luria-broth containing 50 mg/ml of ampicillin at 37 C until OD 600 nm reached 0.5. Protein expression was induced by 0.5 mM isopropyl--D-thiogalactoside. The cells were collected by centrifugation, and the pellet was washed with 0.25 M glucose in 20 mM sodium phosphate buffer (pH 7.0) (buffer A), and resuspended in 5 ml of buffer A. The suspension was frozen and then thawed, sonicated, and centrifuged. The collected supernatant was diluted 3-fold with double distilled water and applied to 15 ml of DE52 column. The column was washed with 1 bed volume of buffer A and 0.05 M NaCl in buffer A, and eluted with 0.5 bed volume of 0.1 M NaCl in buffer A. The eluent was applied directly to 5 ml of Red Sepharose CL6B column. The column was washed with 1 bed volume buffer A and 1 M NaCl in buffer A, and eluted with 1.5 M NaCl in buffer A (Fig. 2A) . The specific activity of the purified enzyme was 3.01 units/mg protein, higher than pig enzyme (1.16 units/mg protein). The recombinant protein was purified to homogeneity as judged by CBB-stained SDS-PAGE (Fig. 2B) .
The substrate specificities of recombinant protein for many carbonyl compounds are summarized in Fig. 3A . The starch-derived AG-free AF we used in experiments was a gift from Danisco A/S (Copenhagen, Denmark). The substrate specificity profile of the recombinant protein is concordant to pig enzyme. 6 ) Among the compounds we tested, AF was the most preferred
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Step (mg) substrate. 2,3-butanedione was a relatively good substrate. Glucronic acid and formaldehyde were reduced weakly and activity against glucose, DL-glycelaldehyde and acetone were not detected under our experimental conditions. The only discrepancy was that recombinant protein has very weak activity against fructose. It is uncertain whether the difference was derived from species differences, or the activity of residual impurities that preferred fructose as substrate. It has been reported that recombinant protein expressed by AKR1E1 reduced 9,10-phaenanthrenequinone effectively. 7, 8) This was confirmed in this study. Moreover, recombinant protein did not catalyze the reverse reaction, viz., NADP þ -dependent AG oxidation, as was observed in the case of pig enzyme. 6) These enzymatic properties support the assumption that the recombinant protein is AF reductase of the mouse.
The high Km value and low molecular activity of the recombinant protein was also concordant to pig liver enzyme.
6) The Km of the recombinant protein was A, Enzyme activity was determined by monitoring the decrease in absorbance at 340 nm due to NADPH consumption. The reaction mixture contained 0.2 mM NADPH, indicated concentration of each substrate and appropriate amount of enzyme in 20 mM phosphate buffer (pH 7.0). The mixture was incubated at 37 C for 10 min. In the reverse reaction assay, 10 mM NADP þ was added as a cofactor and the mixture was incubated at 37 C for 30 min. n.d., not detectable. --, experiment was not performed. B, Lineweaver-Burk plot of AF reducing reaction of recombinant protein. Reaction mixture contained 4 mM NADPH and variety of AF concentrations (0.15, 0.3, 0.6, 1.5, and 3.0 mM) and appropriate amounts of enzyme in 20 mM phosphate buffer (pH 7.0). The enzyme activity was determined by measuring the amount of AG product. Assays were performed in tripricate for each AF concentration. C, Kinetic values of recombinant protein to AF. Kinetic constants were calculated using linear least-squares fitting to a Lineweaver-Burk plot.
1.02 mM, about 2.3-fold higher than that of pig enzyme (0.44 mM), but the difference is within acceptable limits. Molecular activity of recombinant protein was 9.3 s À1 , very close to that of pig enzyme (8.7 s À1 ) (Fig. 3B, C) . Taken together similarities such as in amino acid sequence, substrate specificities, and kinetic properties, it is highly likely that the recombinant protein expressed from the AKR1E1 gene is the mouse ortholog of pig AF reductase.
Although AG is widely used as a marker for diabetes mellitus in the clinical field, the physiological role of AG and its synthetic pathway are poorly understood. For study of AG, application of molecular biological methods should be useful. In the present study, we identified the mouse gene for AF reductase. We intend to elucidate the AF pathway by overexpression or knockout of the AF reductase gene using molecular and biological techniques.
